Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue.
about
Retrospective monte carlo dose calculations with limited beam weight information.Four-dimensional stereotactic radiotherapy for early stage non-small cell lung cancer: a comparative planning study.An analysis of an implantable dosimeter system for external beam therapy.Limiting the risk of cardiac toxicity with esophageal-sparing intensity modulated radiotherapy for locally advanced lung cancersReport of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning.Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters.IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.(Radio)biological optimization of external-beam radiotherapy.Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.Mechanistic modelling of radiotherapy-induced lung toxicity.Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose.The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation.Comparison of Acuros (AXB) and Anisotropic Analytical Algorithm (AAA) for dose calculation in treatment of oesophageal cancer: effects on modelling tumour control probability.NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.Quantification and reduction of cardiac dose in radical radiotherapy for oesophageal cancer.Initial clinical experience with stereotactic lung radiotherapy, based on a biological model-driven prescription method.The photon dose calculation algorithm used in breast radiotherapy has significant impact on the parameters of radiobiological models.Influence of different dose calculation algorithms on the estimate of NTCP for lung complications.Effect of contrast enhanced CT scans on heterogeneity corrected dose computations in the lung.Sensitivity of NTCP parameter values against a change of dose calculation algorithm.Evaluation of treatment plans using various treatment techniques for the radiotherapy of cutaneous Kaposi's sarcoma developed on the skin of feet.Dosimetric comparison of pencil beam and Monte Carlo algorithms in conformal lung radiotherapy
P2860
Q33271980-148F7997-66E5-4F59-83C6-CE5E6345C06BQ33315026-9A44B27E-D43D-41B1-B322-7F233E27809AQ36235680-E06C1100-25AE-4680-988E-08EEBA1AD0BFQ36829707-B5496A26-2D8D-4D0E-B2BF-A5DF28950A62Q37057458-209D8574-C8A0-4878-A5B9-C7400E7EA3AEQ37113684-06B5F676-733D-49A1-B6CE-F932C3EC0339Q37123650-82F6F169-4954-439E-8D8E-EE19AF303DAFQ38428533-2171AC2A-48BF-48CA-B085-B792F1E01D1DQ39115244-F69557DC-FAC5-4D1B-AC2B-D0C47B800821Q39423520-1F2A41EB-AFE6-4758-A0C5-F5DC75FB8360Q41872325-B4D61615-D1AB-4106-A4BB-82028118B11EQ42628995-4A1BF753-723B-4B3C-B774-09B24EF84E67Q43110953-9E9C5205-56B1-4146-BBBB-E5AC1E7DBB5DQ46051924-84FD4786-1E0B-4FE0-AD12-1648650BDCA0Q46849721-40AFD267-91FC-400C-B8A5-8B3CBC323AF1Q47098978-70B7793D-3779-45E0-9CB6-A8874D39E9D1Q48828745-44A1C9AC-E501-4F42-BA87-C16ECF10BA01Q51164172-6D132F16-BE4A-4486-BD02-AEDB9830A10FQ51626488-822A6E67-75AA-46A1-8474-33F87A15D6EAQ51904249-33944C7B-5030-4BAB-856E-919D6ECE30B6Q53245851-5D40BC8F-B64E-4B05-B2E1-13CC76FE9E46Q58799976-D040315C-F8AA-4D4E-BECD-483BAE394A67
P2860
Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Incorporating an improved dose ...... of dose in normal lung tissue.
@en
Incorporating an improved dose ...... of dose in normal lung tissue.
@nl
type
label
Incorporating an improved dose ...... of dose in normal lung tissue.
@en
Incorporating an improved dose ...... of dose in normal lung tissue.
@nl
prefLabel
Incorporating an improved dose ...... of dose in normal lung tissue.
@en
Incorporating an improved dose ...... of dose in normal lung tissue.
@nl
P2093
P1476
Incorporating an improved dose ...... of dose in normal lung tissue.
@en
P2093
Ben J Mijnheer
Eugène M F Damen
Joos V Lebesque
Katrien De Jaeger
Liesbeth J Boersma
Martijn Engelsman
Mischa S Hoogeman
P356
10.1016/S0167-8140(03)00195-6
P577
2003-10-01T00:00:00Z